- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 818451, 12 pages
Inhibition of Activity of GABA Transporter GAT1 by -Opioid Receptor
1Max-Planck-Institute for Biophysics, Max-von-Laue-Straße 3, 60438 Frankfurt, Germany
2Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology and Max-Planck Guest Laboratory, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue Yang Road, Shanghai 200031, China
3Department of Neurobiology and Behavior, Center for the Neurobiology of Learning and Memory, University of California, Irvine, CA 92697, USA
4Shanghai Research Center for Acupuncture and Meridians, 199 Guoshoujing Road, Shanghai 201203, China
5NingXia Key Lab of Cerebrocranial Disease, Ningxia Medical University, 1160 Shengli Street, Ningxia Hui Autonomous Region, Yinchuan 750004, China
6Central Institute of Mental Health, BCCN Heidelberg-Mannheim, J5, 68159 Mannheim, Germany
7Institute for Biophysics, Goethe-University Frankfurt, Max-von-Laue-Straße 1, 60438 Frankfurt, Germany
Received 11 September 2012; Revised 4 November 2012; Accepted 4 November 2012
Academic Editor: Ying Xia
Copyright © 2012 Lu Pu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. D. Rothstein, L. Martin, A. I. Levey et al., “Localization of neuronal and glial glutamate transporters,” Neuron, vol. 13, no. 3, pp. 713–725, 1994.
- Y. He, W. G. Janssen, J. D. Rothstein, and J. H. Morrison, “Differential synaptic localization of the glutamate transporter EAAC1 and glutamate receptor subunit GluR2 in the rat hippocampus,” The Journal of Comparative Neurology, vol. 418, pp. 255–269, 2000.
- J. Levenson, E. Weeber, J. C. Selcher, L. S. Kategayal, D. J. Sweatt, and A. Eskin, “Long-term potentiation and contextual fear conditioning increase neuronal glutamate uptake,” Nature Neuroscience, vol. 5, no. 2, pp. 155–161, 2002.
- L. A. Borden and M. J. Caplan, “GABA transporter heterogeneity: pharmacology and cellular localization,” Neurochemistry International, vol. 29, no. 4, pp. 335–356, 1996.
- T. P. Malan, H. P. Mata, and F. Porreca, “Spinal GABAA and GABAB receptor pharmacology in a rat model of neuropathic pain,” Anesthesiology, vol. 96, no. 5, pp. 1161–1167, 2002.
- Y. Q. Zhang, G. C. Ji, G. C. Wu, and Z. Q. Zhao, “Excitatory amino acid receptor antagonists and electroacupuncture synergetically inhibit carrageenan-induced behavioral hyperalgesia and spinal fos expression in rats,” Pain, vol. 99, no. 3, pp. 525–535, 2002.
- J. Zhang, G. T. Gibney, P. Zhao, and Y. Xia, “Neuroprotective role of δ-opioid receptors in cortical neurons,” American Journal of Physiology, vol. 282, no. 6, pp. C1225–C1234, 2002.
- J. Knabl, R. Witschi, K. Hösl et al., “Reversal of pathological pain through specific spinal GABAA receptor subtypes,” Nature, vol. 451, no. 7176, pp. 330–334, 2008.
- P. Xia, G. Pei, and W. Schwarz, “Regulation of the glutamate transporter EAAC1 by expression and activation of δ-opioid receptor,” European Journal of Neuroscience, vol. 24, no. 1, pp. 87–93, 2006.
- W. Schwarz and Q. B. Gu, “Cellular mechanisms in acupuncture points and affected sites,” in Current Research in Acupuncture, Y. Xia, G. H. Ding, and G.-C. Wu, Eds., pp. 37–51, Springer, 2012.
- J. H. Hu, N. Yang, Y. H. Ma et al., “Hyperalgesic effects of γ-aminobutyric acid transporter I in mice,” Journal of Neuroscience Research, vol. 73, no. 4, pp. 565–572, 2003.
- P. Schloss, W. Mayser, and H. Betz, “Neurotransmitter transporters. A novel family of integral plasma membrane proteins,” FEBS Letters, vol. 307, no. 1, pp. 76–80, 1992.
- S. Keynan and B. I. Kanner, “γ-Aminobutyric acid transport in reconstituted preparations from rat brain: coupled sodium and chloride fluxes,” Biochemistry, vol. 27, no. 1, pp. 12–17, 1988.
- M. P. Kavanaugh, J. L. Arriza, R. A. North, and S. G. Amara, “Electrogenic uptake of γ-aminobutyric acid by a cloned transporter expressed in Xenopus oocytes,” Journal of Biological Chemistry, vol. 267, no. 31, pp. 22007–22009, 1992.
- S. Risso, L. J. DeFelice, and R. D. Blakely, “Sodium-dependent GABA-induced currents in GAT1-transfected HeLa cells,” Journal of Physiology, vol. 490, no. 3, pp. 691–702, 1996.
- D. W. Hilgemann and C. C. Lu, “GAT1 (GABA:Na+:Cl−) cotransport function: database reconstruction with an alternating access model,” Journal of General Physiology, vol. 114, no. 3, pp. 459–475, 1999.
- D. D. F. Loo, S. Eskandari, K. J. Boorer, H. K. Sarkar, and E. M. Wright, “Role of Cl− in electrogenic NA+-coupled cotransporters GAT1 and SGLT1,” Journal of Biological Chemistry, vol. 275, no. 48, pp. 37414–37422, 2000.
- S. Krause and W. Schwarz, “Identification and selective inhibition of the channel mode of the neuronal GABA transporter 1,” Molecular Pharmacology, vol. 68, no. 6, pp. 1728–1735, 2005.
- S. Mager, J. Naeve, M. Quick, C. Labarca, N. Davidson, and H. A. Lester, “Steady states, charge movements, and rates for a cloned GABA transporter expressed in Xenopus oocytes,” Neuron, vol. 10, no. 2, pp. 177–188, 1993.
- S. Mager, N. Kleinberger-Doron, G. I. Keshet, N. Davidson, B. I. Kanner, and H. A. Lester, “Ion binding and permeation at the GABA transporter GAT1,” Journal of Neuroscience, vol. 16, no. 17, pp. 5405–5414, 1996.
- Y. Liu, U. Eckstein-Ludwig, J. Fei, and W. Schwarz, “Effect of mutation of glycosylation sites on the Na+ dependence of steady-state and transient currents generated by the neuronal GABA transporter,” Biochimica et Biophysica Acta, vol. 1415, no. 1, pp. 246–254, 1998.
- A. Bicho and C. Grewer, “Rapid substrate-induced charge movements of the GABA transporter GAT1,” Biophysical Journal, vol. 89, pp. 211–231, 2005.
- U. Eckstein-Ludwig, Y. Fueta, J. Fei, and W. Schwarz, “The neuronal GABA transporter GAT1 as a target for action of antiepileptic drugs,” in Control and Diseases of Sodium Transport Proteins and Channels, Y. Suketa, E. Carafoli, M. Lazdunski, K. Mikoshiba, Y. Okada, and E. M. Wright, Eds., pp. 373–376, Elsevier Press, Amsterdam, The Netherlands, 2000.
- J. S. Han, “Acupuncture and endorphins,” Neuroscience Letters, vol. 361, no. 1–3, pp. 258–261, 2004.
- M. M. Heinricher and H. Fields, “Molecular and effect of delta opioid compounds,” in The Delta Receptor, K. J. Chang, F. Porreca, and J. Woods, Eds., pp. 467–480, Marcel Dekker, New York, NY, USA, 2003.
- H. Fields, “State-dependent opioid control of pain,” Nature Reviews Neuroscience, vol. 5, no. 7, pp. 565–575, 2004.
- C. M. Cahill, A. Morinville, C. Hoffert, D. O'Donnell, and A. Beaudet, “Up-regulation and trafficking of δ opioid receptor in a model of chronic inflammation: implications for pain control,” Pain, vol. 101, no. 1-2, pp. 199–208, 2003.
- K. A. Moore, T. Kohno, L. A. Karchewski, J. Scholz, H. Baba, and C. J. Woolf, “Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord,” Journal of Neuroscience, vol. 22, no. 15, pp. 6724–6731, 2002.
- L. Jasmin, M. V. Wu, and P. T. Ohara, “GABA puts a stop to pain,” CNS and Neurological Disorders, vol. 3, no. 6, pp. 487–505, 2004.
- T. Miyamae, N. Fukushima, Y. Misu, and H. Ueda, “δ Opioid receptor mediates phospholipase C activation via Gi in Xenopus oocytes,” FEBS Letters, vol. 333, no. 3, pp. 311–314, 1993.
- K. A. Trujillo and H. Akil, “Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801,” Science, vol. 251, no. 4989, pp. 85–87, 1991.
- L. Pu, G. B. Bao, N. J. Xu, L. Ma, and G. Pei, “Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates,” Journal of Neuroscience, vol. 22, no. 5, pp. 1914–1921, 2002.
- N. Gong, Y. Li, G. Q. Cai et al., “GABA transporter-1 activity modulates hippocampal theta oscillation and theta burst stimulation-induced long-term potentiation,” Journal of Neuroscience, vol. 29, no. 50, pp. 15836–15845, 2009.
- E. Erbs, L. Faget, G. Scherrer et al., “Distribution of delta opioid receptor-expressing neurons in the mouse hippocampus,” Neuroscience, vol. 221, pp. 203–213, 2012.
- J. Ortiz, H. W. Harris, X. Guitart, R. Z. Terwilliger, J. W. Haycock, and E. J. Nestler, “Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine,” Journal of Neuroscience, vol. 15, no. 2, pp. 1285–1297, 1995.
- N. J. Xu, L. Bao, H. P. Fan et al., “Morphine withdrawal increases glutamate uptake and surface expression of glutamate transporter GLT1 at hippocampal synapses,” Journal of Neuroscience, vol. 23, no. 11, pp. 4775–4784, 2003.
- K. Ullensvang, K. P. Lehre, J. Storm-Mathisen, and N. C. Danbolt, “Differential developmental expression of the two rat brain glutamate transporter proteins GLAST and GLT,” European Journal of Neuroscience, vol. 9, no. 8, pp. 1646–1655, 1997.
- G. Schmalzing, S. Gloor, H. Omay, S. Kroner, H. Appelhans, and W. Schwarz, “Up-regulation of sodium pump activity in Xenopus laevis oocytes by expression of heterologous β1 subunits of the sodium pump,” Biochemical Journal, vol. 279, no. 2, pp. 329–336, 1991.
- A. V. Lafaire and W. Schwarz, “Voltage dependence of the rheogenic Na+/K+ ATPase in the membrane of oocytes of Xenopus laevis,” Journal of Membrane Biology, vol. 91, no. 1, pp. 43–51, 1986.
- L. A. Vasilets, T. Ohta, S. Noguchi, M. Kawamura, and W. Schwarz, “Voltage-dependent inhibition of the sodium pump by external sodium: species differences and possible role of the N-terminus of the α-subunit,” European Biophysics Journal, vol. 21, no. 6, pp. 433–443, 1993.
- Y. Zhu, L. A. Vasilets, J. Fei, L. Guo, and W. Schwarz, “Different functional roles of arginine residues 39 and 61 and tyrosine residue 98 in transport and channel mode of the glutamate transporter EAAC1,” Biochimica et Biophysica Acta, vol. 1665, no. 1-2, pp. 20–28, 2004.
- K. Oguri, I. Yamada-Mori, and J. Shigezane, “Enhanced binding of morphine and nalorphine to opioid delta receptor by glucuronate and sulfate conjugations at the 6-position,” Life Sciences, vol. 41, no. 12, pp. 1457–1464, 1987.
- H. W. D. Matthes, R. Maldonado, F. Simonin et al., “Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene,” Nature, vol. 383, no. 6603, pp. 822–823, 1996.
- C. M. Constantino, I. Gomes, S. D. Stockton, M. P. Lim, and L. A. Devi, “Opioid receptor heteromers in analgesia,” Expert Reviews in Molecular Medicine, vol. 14, article e9, 2012.
- X. Zhang, L. Bao, and J. S. Guan, “Role of delivery and trafficking of δ-opioid peptide receptors in opioid analgesia and tolerance,” Trends in Pharmacological Sciences, vol. 27, no. 6, pp. 324–329, 2006.
- K. G. Commons, “Translocation of presynaptic delta opioid receptors in the ventrolateral periaqueductal gray after swim stress,” Journal of Comparative Neurology, vol. 464, no. 2, pp. 197–207, 2003.
- B. Pomeranz and D. Chiu, “Naloxone blockade of acupuncture analgesia: endorphin implicated,” Life Sciences, vol. 19, no. 11, pp. 1757–1762, 1976.
- D. J. Mayer, D. D. Price, and A. Rafii, “Antagonism of acupuncture analgesia in man by the narcotic antagonist naloxone,” Brain Research, vol. 121, no. 2, pp. 368–372, 1977.
- X. Kang, D. Chao, Q. Gu et al., “δ-Opioid receptors protect from anoxic disruption of Na+ homeostasis via Na+ channel regulation,” Cellular and Molecular Life Sciences, vol. 66, no. 21, pp. 3505–3516, 2009.
- H. Deng, Z. Yang, Y. Li et al., “Interactions of Na+,K+-ATPase and co-expressed δ-opioid receptor,” Neuroscience Research, vol. 65, no. 3, pp. 222–227, 2009.
- Z. J. Yang, G. B. Bao, H. P. Deng et al., “Interaction of δ-opioid receptor with membrane transporters: possible mechanisms in pain suppression by acupuncture,” Journal of Acupuncture and Tuina Science, vol. 6, no. 5, pp. 298–300, 2008.
- D. Marazziti, S. Mandillo, C. Di Pietro, E. Golini, R. Matteoni, and G. P. Tocchini-Valentini, “GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 23, pp. 9846–9851, 2007.
- F. J. S. Lee, L. Pei, A. Moszczynska, B. Vukusic, P. J. Fletcher, and F. Liu, “Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor,” EMBO Journal, vol. 26, no. 8, pp. 2127–2136, 2007.
- B. Bie and Z. Z. Pan, “Trafficking of central opioid receptors and descending pain inhibition,” Molecular Pain, vol. 3, article 37, 2007.
- A. Mansour, C. A. Fox, H. Akil, and S. J. Watson, “Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications,” Trends in Neurosciences, vol. 18, no. 1, pp. 22–29, 1995.
- P. Barbaresi, G. Gazzanelli, and M. Malatesta, “GABA transporter-1 (GAT-1) immunoreactivity in the cat periaqueductal gray matter,” Neuroscience Letters, vol. 250, no. 2, pp. 123–126, 1998.
- M. W. Quick, J. L. Corey, N. Davidson, and H. A. Lester, “Second messengers, trafficking-related proteins, and amino acid residues that contribute to the functional regulation of the rat brain GABA transporter GAT1,” Journal of Neuroscience, vol. 17, no. 9, pp. 2967–2979, 1997.
- L. G. Lou, L. Ma, and G. Pei, “Nociceptin/Orphanin FQ activates protein kinase C, and this effect is mediated through phospholipase C/Ca2+ pathway,” Biochemical and Biophysical Research Communications, vol. 240, no. 2, pp. 304–308, 1997.
- L. G. Lou and G. Pei, “Modulation of protein kinase C and cAMP-dependent protein kinase by δ-opioid,” Biochemical and Biophysical Research Communications, vol. 236, no. 3, pp. 626–629, 1997.
- A. N. M. Schoffelmeer, L. J. M. J. Vanderschuren, T. J. De Vries, F. Hogenboom, G. Wardeh, and A. H. Mulder, “Synergistically interacting dopamine D1 and NMDA receptors mediate nonvesicular transporter-dependent GABA release from rat striatal medium spiny neurons,” Journal of Neuroscience, vol. 20, no. 9, pp. 3496–3503, 2000.
- M. L. Beckman and M. W. Quick, “Neurotransmitter transporters: regulators of function and functional regulation,” Journal of Membrane Biology, vol. 164, no. 1, pp. 1–10, 1998.
- J. L. Corey, N. Davidson, H. A. Lester, N. Brecha, and M. W. Quick, “Protein kinase C modulates the activity of a cloned γ-aminobutyric acid transporter expressed in Xenopus oocytes via regulated subcellular redistribution of the transporter,” Journal of Biological Chemistry, vol. 269, no. 20, pp. 14759–14767, 1994.
- S. L. Deken, M. L. Beckman, L. Boos, and M. W. Quick, “Transport rates of GABA transporters: regulation by the N-terminal domain and syntaxin 1A,” Nature Neuroscience, vol. 3, no. 10, pp. 998–1003, 2000.
- M. L. Beckman, E. M. Bernstein, and M. W. Quick, “Protein kinase C regulates the interaction between a GABA transporter and syntaxin 1A,” Journal of Neuroscience, vol. 18, no. 16, pp. 6103–6112, 1998.
- G. Ogimoto, G. A. Yudowski, C. J. Barker et al., “G protein-coupled receptors regulate Na+,K+-ATPase activity and endocytosis by modulating the recruitment of adaptor protein 2 and clathrin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 7, pp. 3242–3247, 2000.
- S. K. Shenoy and R. J. Lefkowitz, “Multifaceted roles of β-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling,” Biochemical Journal, vol. 375, no. 3, pp. 503–515, 2003.
- O. El Far and H. Betz, “G-protein-coupled receptors for neurotransmitter amino acids: C-terminal tails, crowded signalosomes,” Biochemical Journal, vol. 365, no. 2, pp. 329–336, 2002.
- Y. Zhu, J. Fei, and W. Schwarz, “Expression and transport function of the glutamate transporter EAAC1 in Xenopus oocytes is regulated by syntaxin 1A,” Journal of Neuroscience Research, vol. 79, no. 4, pp. 503–508, 2005.
- P. Illes, “Modulation of transmitter and hormone release by multiple neuronal opioid receptors.,” Reviews of Physiology Biochemistry and Pharmacology, vol. 112, pp. 139–233, 1989.
- M. H. Heijna, F. Hogenboom, A. H. Mulder, and A. N. M. Schoffelmeer, “Opioid receptor-mediated inhibition of 3H-dopamine and 14C-acetylcholine release from rat nucleus accumbens slices. A study on the possible involvement of K+ channels and adenylate cyclase,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 345, no. 6, pp. 627–632, 1992.
- D. A. Eisinger, H. Ammer, and R. Schulz, “Chronic morphine treatment inhibits opioid receptor desensitization and internalization,” Journal of Neuroscience, vol. 22, no. 23, pp. 10192–10200, 2002.
- D. Chao and Y. Xia, “Ionic storm in hypoxic/ischemic stress: can opioid receptors subside it?” Progress in Neurobiology, vol. 90, no. 4, pp. 439–470, 2010.